Henry Schein (HSIC)
NASDAQ:HSIC
Want to see HSIC full AI Analyst Report?
HSIC Stock Chart & Stats
$78.83
-$1.28(-1.78%)
At close: 4:00 PM EST
$78.83
-$1.28(-1.78%)
Day’s Range― - ―
52-Week Range$61.95 - $89.29
Previous CloseN/A
Volume226.89K
Average Volume (3M)1.28M
Market Cap
$8.27B
Enterprise Value$11.90B
Total Cash (Recent Filing)$138.00M
Total Debt (Recent Filing)$3.75B
Price to Earnings (P/E)19.4
Beta0.33
Next Earnings
Aug 11, 2026EPS Estimate
1.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.34
Shares Outstanding113,916,756
10 Day Avg. Volume1,389,561
30 Day Avg. Volume1,278,409
Financial Highlights & Ratios
PEG Ratio3.22
Price to Book (P/B)2.83
Price to Sales (P/S)0.70
P/FCF Ratio16.05
Enterprise Value/Market Cap1.44
Enterprise Value/Revenue0.89
Enterprise Value/Gross Profit2.99
Enterprise Value/Ebitda11.95
Forecast
1Y Price Target
$87.43Price Target Upside10.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
EPS Forecast (FY)5.35
Revenue Forecast (FY)$13.75B
Bulls Say, Bears Say
Bulls Say
Improved Liquidity And Capital Allocation FlexibilityImproved cash flow and management guidance above expectations enhance liquidity and provide flexibility to invest in high-growth, high-margin areas and efficiency initiatives.
Market Leadership And Customer LoyaltyMarket leadership in dental products and strong customer loyalty create pricing power and support recurring revenue from core customers.
Specialty And Equipment Revenue DiversificationRobust growth in specialty products and equipment, including deployment of AI-enabled practice tools and new imaging software partnerships, supports a shift toward higher-margin revenue streams.
Bears Say
Competitive Pressure In Medical DistributionIntense competition from Medline in medical distribution risks market share erosion and puts pressure on medical segment revenue growth.
High Leverage And Balance Sheet RiskSubstantial net debt and leverage elevate financial risk and could restrict strategic investment or increase vulnerability to adverse market conditions.
Mature End Market Growth ConstraintsA mature dental end market with only modest growth limits upside and constrains the pace of long-term organic revenue expansion.
Henry Schein News
HSIC FAQ
What was Henry Schein’s price range in the past 12 months?
Henry Schein lowest stock price was $61.95 and its highest was $89.29 in the past 12 months.
What is Henry Schein’s market cap?
Henry Schein’s market cap is $8.27B.
When is Henry Schein’s upcoming earnings report date?
Henry Schein’s upcoming earnings report date is Aug 11, 2026 which is in 87 days.
How were Henry Schein’s earnings last quarter?
Henry Schein released its earnings results on May 05, 2026. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.218 by $0.102.
Is Henry Schein overvalued?
According to Wall Street analysts Henry Schein’s price is currently Undervalued.
Does Henry Schein pay dividends?
Henry Schein does not currently pay dividends.
What is Henry Schein’s EPS estimate?
Henry Schein’s EPS estimate is 1.23.
How many shares outstanding does Henry Schein have?
Henry Schein has 113,916,756 shares outstanding.
What happened to Henry Schein’s price movement after its last earnings report?
Henry Schein reported an EPS of $1.32 in its last earnings report, beating expectations of $1.218. Following the earnings report the stock price went up 3.263%.
Which hedge fund is a major shareholder of Henry Schein?
Currently, no hedge funds are holding shares in HSIC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Henry Schein Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$87.43 (10.91% Upside)
$87.43 (10.91% Upside)
Blogger Sentiment
Bullish
HSIC Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 77.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $7.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.19%
12-Months-Change
Fundamentals
Return on Equity
11.86%
Trailing 12-Months
Asset Growth
7.86%
Trailing 12-Months
Company Description
Henry Schein
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
HSIC Company Deck
HSIC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong operational and financial positives — solid revenue growth (+6.3% total, 2.5% internal), non-GAAP margin expansion (+28 bps), adjusted EBITDA growth (+11.6%), cloud/customer momentum (+25% cloud subscribers), rapid e-commerce adoption (80%+ U.S. dental e-commerce), and an explicit multi-year value-creation plan with a $125 million 2026 run-rate target and a >$200 million longer-term target. Offsetting these were manageable but important risks: a Q1 GAAP margin dip and slight GAAP net income decline, negative Q1 operating cash flow (seasonal), softness in medical diagnostics due to a light flu season, digital equipment ASP pressure, restructuring costs ($12M in Q1), and exposure to rising oil/freight costs. Overall, the positives (growth, margin expansion on a non-GAAP basis, technology and e-commerce traction, and clear cost-transformation initiatives) materially outweigh the near-term headwinds and execution costs, supporting an optimistic outlook grounded with prudent caveats around macro and timing of savings.View all HSIC earnings summariesHSIC Revenue Breakdown
84.48% Global Distribution and Value-Added Services
11.71% Global Specialty Products
5.12% Global Technology
-1.31% Eliminations
HSIC Stock 12 Month Forecast
Average Price Target
$87.43
▲(10.91% Upside)
Technical Analysis
Ownership Overview
1.36% Insiders
27.76% Mutual Funds
19.60% Other Institutional Investors
28.44% Public Companies and
Individual Investors